Tuesday, 22 October 2019

CRO News

  • Silver Leaf Oak acquires 10% stake in Syngene

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2014

    Silver Leaf Oak (Mauritius) Limited, an investment vehicle advised by India Value Fund Advisors (IVFA) has agreed to acquire a minority 10% stake in Syngene International, Biocon's Research...Read more

  • PPD creates a Pediatric Investigator Network

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2015

    Pharmaceutical Product Development (PPD) has formalized relationships with eight investigator sites as part of a Pediatric Investigator Network (PIN). The company has been established to fu...Read more

  • Research support 'BYOD' approach in Clinical Trials

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2016

    ICON has announced research showing many pharmaceutical and clinical research organisations (CROs) support the use of a 'Bring Your Own Device' (BYOD) approach in clinical studies, enabling...Read more

  • Advaxis, Medimmune collaborate over immune-oncology trial

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2014

    MedImmune enters into a partnership with Advaxis for a immuno-oncology combination clinical trial. The immunotherapy study will evaluate the safety and efficacy of MedImmune's investigation...Read more

  • Syngene files DRHP, seeks approval for IPO

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 29 Apr, 2015

    This is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene. Biocon along with its subsidiary Biocon Research Limited (BRL) currently holds an 84.5 percent equity sta...Read more

  • Dr Reddy's on Union Finance Budget 2016

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, -0001

    "On the healthcare front," says Mr Satish Reddy, Chairman, Dr Reddy's Laboratories, "the budgetary emphasis on the sector was fairly muted. While certain initiatives such as the new health ...Read more

  • Now Investigators not permitted more than 3 trials at a time

    CRO |  News | By Rahul Koul Koul | 0 Comment | 11 Jul, 2014

    The ministry of health and family welfare, government of India has constituted an expert commitee under the chairmanship of Prof. Ranjit Roy Chaudhury to formulate policy and guidelines for...Read more

  • Syngene's new CEO to commence office in Mar '16

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2016

    Mr Hunt will take charge as CEO post the retirement of current CEO Mr Peter Bains in March 2016. Mr Bains, who has worked closely with Syngene as a Director since 2010 and was appointed as ...Read more

  • Caught in crossfire?

    CRO |  Features | By Rahul Koul Koul | 0 Comment | 10 Sep, 2013

    As per records of the Drugs Controller General of India (DCGI) in the Supreme Court, India approved 475 clinical trials for 'new chemical entities' not used as drugs elsewhere in the world ...Read more

  • GVK BIO , USFDA collaborate for drug repositioning

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    GVK Biosciences today announced that it has licensed its popular SAR, PK and Toxicity Database (GOSTAR) to the US Food and Drug Administration (USFDA). The material transfer agreement forms...Read more

  • Why we need clinical trials

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

    Commemorating the huge impact that clinical trials have had on improving healthcare in the world, today, May 20, 2013 was celebrated as the International Clinical Trials Day. The day is cel...Read more

  • University of Dundee licenses GVK BIO online SAR database

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 10 Apr, 2013

    GVK Biosciences today announced that it has licensed its online SAR database - GOSTAR to the Drug Discovery Unit (DDU) at the University of Dundee. GOSTAR, a manually curated database, has ...Read more

  • CRAMS: The next big wave

    CRO |  Features | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    A recent study based on the analysis of intellectual property generated by Indian CROs suggests a rather discouraging outlook of drug discovery in India. While this is a matter of concern f...Read more

  • DIA to organize eCTD training workshop

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jan, 2013

    Leading Industry body DIA (Drug Information Association is organizing a day long eCTD training workshop for pharma professionals on February 4 in Mumbai. This workshop is focused on enablin...Read more

  • SIRO Clinpharm unveils new look

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jan, 2013

    SIRO Clinpharm, a leading Mumbai-based clinical research organization, which grew at a strong 40% in 2011-12, unveiled its new brand identity recently. The new look, along with a new logo i...Read more

  • GVK BIO, Onconova ink pact to develop cancer drugs

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    GVK BIO, a leading Hyderabad-based contract research and development organization recently announced that they have entered into a joint partnership with Onconova Therapeutics to develop ne...Read more